BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 76 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.9%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,000 | 0.0% | 336 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $15,000 | -70.6% | 336 | -76.8% | 0.00% | -50.0% |
| Q1 2019 | $51,000 | 0.0% | 1,449 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $51,000 | +37.8% | 1,449 | +46.7% | 0.00% | 0.0% |
| Q3 2018 | $37,000 | -9.8% | 988 | -6.1% | 0.00% | -50.0% |
| Q2 2018 | $41,000 | -24.1% | 1,052 | -49.7% | 0.00% | – |
| Q1 2018 | $54,000 | +145.5% | 2,093 | +150.7% | 0.00% | -100.0% |
| Q4 2017 | $22,000 | -63.9% | 835 | +62.1% | 0.00% | -75.0% |
| Q3 2017 | $61,000 | – | 515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |